7:06 am Cempra announces that solithromycin demonstrated no QT effects at single intravenous doses of 800 mg in a Thorough QT study

7:06 am Cempra announces that solithromycin demonstrated no QT effects at single intravenous doses of 800 mg in a Thorough QT study

more

View todays social media effects on CEMP

View the latest stocks trending across Twitter. Click to view dashboard

See who Cempra is hiring next, click here to view

Share this post